| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |